Internal Grants Program
Masonic Cancer Center Internal Grants Program
Six internal grant mechanisms were available through the Masonic Cancer Center in 2013. The goal of this overall program is to foster the development of and provide support for novel research ideas that focus on a problem in cancer. In turn, the Cancer Center expects that these internal awards will lead to nationally peer reviewed funding. The application process for 2013 is outlined below.
Deadlines at a Glance
- Mandatory Statement of Intent (for planning purposes only): September 20, 2013
- Full Application Deadline November 1, 2013
- Review of Applications November 2013
- Notification of Awards 1st Week in December
- Latest Date for Protocol Approval or Proof of Submission January 1, 2014
- Start Date of Awards January 1, 2014
Pilot Grant Mechanisms
The objective of the Brainstorm Awards is to foster interdisciplinary collaborations encompassing novel, hypothesis-driven studies of cancer or a cancer-related topic. The proposed project must be a joint, collaborative effort by at least two Cancer Center members from different programs or different disciplines, and must represent a new collaborative proposal. The Masonic Cancer Center is especially interested in Brainstorm Award applications that are focused on projects relevant to solid tumor oncology with translational potential. Projects that meet these criteria will be prioritized for funding, although it is not a prerequisite for application submission.
Cancer Detection, Treatment and Survivorship Awards
The research areas supported by the CaDeTS pilot grant may address any topic related to cancer screening, treatment outcomes or survivorship. Preference will be given to proposals involving two or more CaDeTS investigators.
Cancer Prevention & Control Awards
One pilot will be available to support research in nutrition, or tobacco regulatory science, or studies that combine nutrition and tobacco related hypotheses.
For details about what tobacco regulatory science includes, please go to the following link: http://prevention.nih.gov/tobacco/research.aspx.
Hematologic Malignancy Innovations Awards
The objective of the Hematologic Malignancy Innovation Award is to foster interdisciplinary collaborations encompassing novel basic or translational studies of hematologic malignancies. The proposed project must be a joint, collaborative effort by at least two Cancer Center members from different programs or different disciplines, and must represent a new collaborative proposal.
Minnesota Chemoprevention Consortium (MC2) Awards
The objective of the Minnesota Chemoprevention Consortium Seed Grant is to stimulate collaborative research on topics directly relevant to the effective development and delivery of cancer chemoprevention agents, either naturally occurring or synthetic. The proposal must involve a collaboration between at least two principal investigators from one of the following: Hormel Institute, UMN Twin Cities, UMN Southern Research and Outreach Center, and the Mayo Clinic.
Translational Breast Cancer Research Awards
The objective of the Translational Breast Cancer Research Awards is to support research in the biology, prevention, detection, diagnosis, and/or treatment of breast cancer.
Eligibility and Evaluation Criteria
- These Pilot Grants are available to Masonic Cancer Center members with faculty appointments at the University of Minnesota.
- Applications must have a cancer or cancer-related theme.
- The funds must be designated for the direct support of research. In general, funds should be used for supplies and support of research personnel (graduate students or technicians). Funds cannot be used to support faculty salaries. If faculty is required by the applicant’s home department, a letter from the department head committing to the cost-shared effort is required. Only equipment purchases that are directly required for the research are appropriate. No indirect costs should be included in the budget.
- The primary criteria for funding will be innovation, the quality of the research approach, and the potential for future outside funding to sustain or further develop the program. Proposed research must be hypothesis-driven and have the goal of using the award as a springboard to obtaining long-term support from federal/external sources.
- All applicants are required to have proper approvals (IRB/IACUC/IBC) before an award will be issued. Applicants are highly encouraged to apply for proper approvals at or prior to the time of submission. This will ensure that the study is approved by the start date of the award.
Applying for Multiple Awards
Applicants may submit to multiple mechanisms only if separate, unique applications are submitted. For each separate application, the PI must submit a separate Statement of Intent.
Each application must meet the format and content requirements outlined below. Any application submitted late or incomplete will not be considered for review.
- Submit Statement of Intent online: due Friday, Septmber 20, 2013 by 11:59 p.m.
- Save copy to serve as a cover sheet of final application
- Application format should follow NIH PHS 398 format whenever possible
- Font size - at least 11 pt, Arial preferred
- The proposal should contain the following information:
- Cover Seet (one page maximum)
- A copy of the statement of intent may serve as the cover sheet.
- Research Plan, single-spaced (three page maximum)
- Specific Aims
- Research Strategy (Significance, Innovation, Approach)
- Explanation of how proposed study will be the basis for future funding
- Should not include preprints, reprints, or other forms of freestanding preliminary data as appendices
- References (no page limit)
- Biosketches for all key personnel—follow current NIH format (4 pages per Biosketch)
- Current & Pending Support for all key personnel - follow NIH format, include federal and non-federal support
- Detailed budget and justification, NIH format, project period:1/1/14 – 12/31/14
- Research personnel (grad. students, lab staff, technicians etc.)— no faculty effort allowed unless required by home department (in which case, home department covers the effort, and a letter from department head is required along with application)
- Research supplies
- Core service expenses (e.g. flow cytometry, tissue procurement,etc.)
- Small equipment (less that $2,500)
- Animal costs
- See each mechanism description for maximum requested amount
- No indirect costs (internal award)
- Cover Seet (one page maximum)
Final Application due Friday, November 1, 2013, at 4:30pm – submit application with cover page as a single PDF file to:
Aaron Schilz, Research Grant Coordinator at email@example.com.
NOTE: A PRF is not required at the time of submission, but PIs will be required to submit a fully routed PRF at the time of award.
|Award Mechanism ||Anticipated Awards||Award Amounts |
|Cancer Detection, Treatment |
and Survivorship Award
|Cancer Prevention & Control Award||1-2||$25,000|
|Hematologic Malignancy Innovations Award||2||$25,000|
|Minnesota Chemoprevention |
Consortium (MC2) Award
|1-2||$50,000 w/o Mayo collaboration |
$100,000 w/ Mayo collaboration
|Translational Breast Cancer Research Award||2||$25,000|
Each mechanism has an internally-selected committee that will review applications. The committee will make recommendations for funding to the Masonic Cancer Center Director. De-identified, written reviews/critiques will be sent to all applicants.
Applicants will be notified of the review outcome by mid-December. Awards will be made for one year, with an anticipated activation date of January 1, 2014. Note that all IRB/IACUC/IBC approvals (if applicable) MUST be received by start date of the grant.
Principal investigators of funded projects will be required to provide a final report and an accounting of all funds expended at the completion of the project. If the project extends beyond awarded dates, a progress report will be required along with a request for an extension. Reports are to be submitted to each mechanism’s respective director.
During a period of up to 7 years following the end of the pilot award, if any grants or publications are obtained as a result of this pilot funding, awardees are required to submit this information to the Research Grant Coordinator at the Masonic Cancer Center.
Grant Program Contact
All questions related to the application process, requirements, or eligibility should be directed to:
Aaron Schilz, Research Grant Coordinator
Any questions regarding the applicability of research should be directed to:
David Largaespada, Ph.D.